Follow The Filings

UTZ Utz Brands Inc.

Consumer Staples, filed as UTZ BRANDS INC (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 0.0%
  • $12M
  • 1 new 1 add

In 2026 Q2 Lee Ainslie opened a position in Utz Brands, and First Eagle Investment Management added.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.02%
  2. Lee Ainslie New 0.02%

Who owns UTZ

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.02% Add +16.7% 1,318,750 $10M History
Lee Ainslie, Maverick Capital 0.02% New 0.02% 253,475 $2M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by UTZ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UTZ insider trades
  • $2.6M bought by 7 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Theresa Robbins Shea EVP, Chief Legal Officer
    Buy
    $6,922 702 shares at $9.86 +1.3% to stake
    Traded Dec 31, 2025 Filed Jan 6
    ↗
  2. James Sponaugle EVP & Chief People Officer
    Buy
    $6,695 679 shares at $9.86 +1.3% to stake
    Traded Dec 31, 2025 Filed Jan 6
    ↗
  3. Series R of UM Partners, LLC 10% owner
    Buy
    $144K 15,000 shares at $9.59 +2.4% to stake
    Traded Nov 20–24 Filed Nov 24, 2025
    ↗
  4. Series U of UM Partners, LLC 10% owner
    Buy
    $815K 85,000 shares at $9.59 +2.4% to stake
    Traded Nov 20–24 Filed Nov 24, 2025
    ↗
  5. Dylan Lissette Director
    Buy
    $70K 7,010 shares at $9.99 +4.6% to stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
    ↗
  6. Dylan Lissette Director
    Buy
    $79K 7,901 shares at $9.99 +5.4% to stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
    ↗
  7. Howard A Friedman CEO
    Buy
    $76K 7,200 shares at $10.58 +12% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  8. William J. Kelley Jr. CFO
    Buy
    $4,994 477 shares at $10.47 +3.6% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  9. Theresa Robbins Shea EVP, Chief Legal Officer
    Buy
    $9,986 965 shares at $10.35 +1.8% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  10. Dylan Lissette Director
    Buy
    $336K 31,750 shares at $10.58 +28% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  11. Series U of UM Partners, LLC 10% owner
    Buy
    $891K 85,000 shares at $10.48 +2.5% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  12. Series R of UM Partners, LLC 10% owner
    Buy
    $157K 15,000 shares at $10.48 +2.5% to stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 stock grants, 28 share withholdings for taxes, and 5 gifts.

Congress

2 members of Congress traded UTZ in the last three years: 2 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Josh Gottheimer D-NJ-5Joint Sell $1K–$15K Dec 8, 2025 filed Jan 14
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K May 15, 2025 filed Jun 6, 2025
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 24, 2025 filed Apr 7, 2025

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,5.03,9.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.41B $1.41B $1.44B
Gross profit $449.06M $494.78M $358.3M
Gross margin * 31.9% 35.1% 24.9%
Net income -$0.392M $15.97M $0.8M
Net margin * 0.0% 1.1% 0.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $372.19M $317.26M $384.4M
Total non-current assets $2.47B $2.41B $2.41B
Total assets $2.84B $2.73B $2.79B
Total current liabilities $237.43M $285.27M $323.2M
Total non-current liabilities $1.15B $1.06B $1.13B
Total equity $703.15M $702.45M $713.7M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $48.19M $106.17M $112.2M
Cash from investing -$76.07M $74.96M -$86.9M
Cash from financing $58.91M -$177.01M $39M
Net change in cash $31.03M $4.12M $64.3M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.